IL225908A0 - New specific inhibitors for 3ns hcv protease - Google Patents
New specific inhibitors for 3ns hcv proteaseInfo
- Publication number
- IL225908A0 IL225908A0 IL225908A IL22590813A IL225908A0 IL 225908 A0 IL225908 A0 IL 225908A0 IL 225908 A IL225908 A IL 225908A IL 22590813 A IL22590813 A IL 22590813A IL 225908 A0 IL225908 A0 IL 225908A0
- Authority
- IL
- Israel
- Prior art keywords
- protease inhibitors
- novel specific
- specific hcv
- hcv
- novel
- Prior art date
Links
- 229940124771 HCV-NS3 protease inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40898910P | 2010-11-01 | 2010-11-01 | |
| PCT/US2011/058404 WO2012061248A2 (en) | 2010-11-01 | 2011-10-28 | Novel specific hcv ns3 protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL225908A0 true IL225908A0 (en) | 2013-06-27 |
Family
ID=46025037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL225908A IL225908A0 (en) | 2010-11-01 | 2013-04-23 | New specific inhibitors for 3ns hcv protease |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8729014B2 (enExample) |
| EP (1) | EP2635570B1 (enExample) |
| JP (1) | JP5828903B2 (enExample) |
| CN (1) | CN103328466B (enExample) |
| AU (1) | AU2011323658A1 (enExample) |
| BR (1) | BR112013010836A2 (enExample) |
| CA (1) | CA2815855C (enExample) |
| IL (1) | IL225908A0 (enExample) |
| MX (1) | MX2013004906A (enExample) |
| WO (1) | WO2012061248A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103096891A (zh) | 2010-06-24 | 2013-05-08 | 判米德有限公司 | 利用羟氯喹或羟氯喹和抗病毒剂的组合治疗丙型肝炎病毒相关疾病 |
| JP5828903B2 (ja) | 2010-11-01 | 2015-12-09 | アールエフエス ファーマ，エルエルシー | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
| EP2723337A1 (en) | 2011-06-23 | 2014-04-30 | Panmed Ltd. | Treatment of hepatitis c virus |
| EP2802574A4 (en) | 2012-01-12 | 2015-06-24 | Rfs Pharma Llc | INHIBITORS OF HCV NS3 PROTEASE |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| ES2735355T3 (es) | 2013-03-15 | 2019-12-18 | Gilead Sciences Inc | Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C |
| JP2017513852A (ja) * | 2014-04-15 | 2017-06-01 | コクリスタル ファーマ，インコーポレイテッド | Ｃ型肝炎ウイルスの強力及び選択的な阻害剤 |
| CN105315261A (zh) * | 2014-08-04 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Hcv ns3蛋白酶抑制剂的钠盐 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000536A1 (en) | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| UA79749C2 (en) | 1996-10-18 | 2007-07-25 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| ATE297946T1 (de) | 2000-04-03 | 2005-07-15 | Vertex Pharma | Inhibitoren von serin proteasen, speziell der hepatitis-c-virus ns3-protease |
| EP1425029A4 (en) | 2001-08-10 | 2006-06-07 | Palatin Technologies Inc | PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| US7041698B2 (en) | 2002-05-20 | 2006-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EA010017B1 (ru) | 2003-07-10 | 2008-06-30 | Ачиллион Фармасьютикалз, Инк. | Замещённые арилтиомочевины, применимые в качестве ингибиторов репликации вирусов |
| SI1713823T1 (sl) | 2004-01-30 | 2010-04-30 | Medivir Ab | Inhibitorji HCV NS-3 serin proteaze |
| MXPA06013404A (es) | 2004-05-20 | 2007-01-23 | Schering Corp | Prolinas sustituidas como inhibidores de serina proteasa ns3 de virus de hepatitis c. |
| US7323447B2 (en) * | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN100486397C (zh) | 2005-04-19 | 2009-05-06 | 皇家飞利浦电子股份有限公司 | 包括红色发射陶瓷发光转换器的照明系统 |
| US7470664B2 (en) | 2005-07-20 | 2008-12-30 | Merck & Co., Inc. | HCV NS3 protease inhibitors |
| JP4705984B2 (ja) | 2005-08-01 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｃｖｎｓ３プロテアーゼ阻害剤としての大環状ペプチド |
| JP2009524681A (ja) | 2006-01-27 | 2009-07-02 | フェノミックス コーポレーション | Ｃ型肝炎ウイルスセリンプロテアーゼインヒビターおよびそのための使用 |
| CN101495457A (zh) * | 2006-07-05 | 2009-07-29 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| JP5035251B2 (ja) | 2006-11-24 | 2012-09-26 | 株式会社島津製作所 | Ｘ線透視撮影装置 |
| US20080287449A1 (en) | 2007-04-26 | 2008-11-20 | Deqiang Niu | Aza-tripeptide hepatitis c serine protease inhibitors |
| CN101977621A (zh) | 2007-12-05 | 2011-02-16 | 益安药业 | 氟化三肽hcv丝氨酸蛋白酶抑制剂 |
| TWI487522B (zh) | 2007-12-21 | 2015-06-11 | 賽基艾維洛米斯研究股份有限公司 | Ｈｃｖ蛋白酶抑制劑及其用途（一） |
| US8293705B2 (en) | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| KR20110005869A (ko) | 2008-04-15 | 2011-01-19 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제 |
| KR101781789B1 (ko) * | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물 |
| JP5828903B2 (ja) | 2010-11-01 | 2015-12-09 | アールエフエス ファーマ，エルエルシー | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
-
2011
- 2011-10-28 JP JP2013537733A patent/JP5828903B2/ja not_active Expired - Fee Related
- 2011-10-28 CN CN201180063866.1A patent/CN103328466B/zh not_active Expired - Fee Related
- 2011-10-28 WO PCT/US2011/058404 patent/WO2012061248A2/en not_active Ceased
- 2011-10-28 BR BR112013010836A patent/BR112013010836A2/pt not_active IP Right Cessation
- 2011-10-28 MX MX2013004906A patent/MX2013004906A/es active IP Right Grant
- 2011-10-28 US US13/284,641 patent/US8729014B2/en not_active Expired - Fee Related
- 2011-10-28 AU AU2011323658A patent/AU2011323658A1/en not_active Abandoned
- 2011-10-28 CA CA2815855A patent/CA2815855C/en not_active Expired - Fee Related
- 2011-10-28 EP EP11838590.5A patent/EP2635570B1/en not_active Not-in-force
-
2013
- 2013-04-23 IL IL225908A patent/IL225908A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013542955A (ja) | 2013-11-28 |
| CA2815855A1 (en) | 2012-05-10 |
| JP5828903B2 (ja) | 2015-12-09 |
| US8729014B2 (en) | 2014-05-20 |
| EP2635570A4 (en) | 2014-04-16 |
| AU2011323658A1 (en) | 2013-05-23 |
| CN103328466A (zh) | 2013-09-25 |
| CN103328466B (zh) | 2016-08-03 |
| CA2815855C (en) | 2016-02-02 |
| WO2012061248A2 (en) | 2012-05-10 |
| WO2012061248A3 (en) | 2012-08-02 |
| EP2635570B1 (en) | 2017-12-13 |
| EP2635570A2 (en) | 2013-09-11 |
| MX2013004906A (es) | 2013-12-06 |
| US20120129765A1 (en) | 2012-05-24 |
| BR112013010836A2 (pt) | 2019-09-24 |
| WO2012061248A8 (en) | 2013-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201202631B (en) | Hcv protease inhibitors | |
| HUS1700039I1 (hu) | Makrociklusos prolinból leszármaztatható HCV szerin proteáz inhibitorok | |
| ZA201008988B (en) | Hcv protease inhibitors | |
| EP2575866A4 (en) | HCV NS5A INHIBITORS | |
| EP2575475A4 (en) | HCV NS5A INHIBITORS | |
| EP2398474A4 (en) | HCV NS5A SHEMMER | |
| EP2410841A4 (en) | SUBSTITUTED BICYCLIC HCV INHIBITORS | |
| EP2618665A4 (en) | HCV NS3 proteinase inhibitor | |
| IL233818A0 (en) | Inhibitors to ns5a hcv | |
| ZA201104911B (en) | Inhibitors of hcv ns5a | |
| EP2802574A4 (en) | INHIBITORS OF HCV NS3 PROTEASE | |
| EP2432318A4 (en) | NS3 PROTEASE INHIBITORS OF BIPACROCYCLIC HEPATITIS C VIRUS | |
| BRPI0923184A2 (pt) | inibidores de hcv ns3 protease | |
| EP2576564A4 (en) | MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS | |
| EP2658859A4 (en) | MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS | |
| ZA201107636B (en) | Protease inhibitors | |
| IL225908A0 (en) | New specific inhibitors for 3ns hcv protease | |
| EP2740734A4 (en) | HCV Protease Inhibitors | |
| EP2364159A4 (en) | DETERIORIC MACROCYCLIC INHIBITORS OF NS3 VIRAL PROTEASE | |
| EP2509957A4 (en) | INHIBITORS OF CYSTEINE PROTEASES | |
| EP2313426A4 (en) | NEW PROTEASE INHIBITORS | |
| HK1188456A (en) | Novel specific hcv ns3 protease inhibitors | |
| SG2014011258A (en) | Hcv protease inhibitors | |
| GB201010084D0 (en) | Cysteine protease inhibitors |